Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444730 · ClinicalTrials.gov registry record
Urology Database for Outcomes Research
A clinical trial, sponsored by Kenneth Peters, MD.
- Completed
- Registry status
- 860
- Enrollment target
NCT00444730: Completed study, sponsored by Kenneth Peters, MD.
NCT00444730 is a clinical trial that has completed, run by Kenneth Peters, MD. The registered enrollment target is 860 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00444730 has completed, sponsored by Kenneth Peters, MD.
- COMPLETED
- Registry status
- 860 participants
- Enrollment target
Study Summary
The purpose of initiating the urology database is to collect relevant retrospective data via chart review related to patients undergoing radical prostatectomy via the retropubic, perineal, laparoscopic, and robotic assisted laparoscopic approaches and InterStim implantation. This data will be utilized to evaluate the health benefits and outcomes of each of these procedures to enhance care and treatment.
Interventions
- PROCEDURE Radical Prostatectomy
- PROCEDURE InterStim Implantation
- PROCEDURE Pelvic organ prolapse repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 860 participants |
| Start Date | 2007-01 |
| Est. Completion | 2014-08 |
What the finished NCT00444730 record still lists
NCT00444730 is an observational study that tracks outcomes without assigning an intervention. The registered 860 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Radical Prostatectomy is the first listed.
NCT00444730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00444730 about?
NCT00444730 is a clinical study titled "Urology Database for Outcomes Research". The purpose of initiating the urology database is to collect relevant retrospective data via chart review related to patients undergoing radical prostatectomy via the retropubic, perineal, laparoscopic, and robotic assisted laparoscopic approaches and InterStim implantation. This data will be utiliz...
What is the current status of trial NCT00444730?
This trial is currently completed. The enrollment target is 860 participants. The study started on 2007-01. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00444730?
The interventions under investigation include: Radical Prostatectomy (PROCEDURE), InterStim Implantation (PROCEDURE), Pelvic organ prolapse repair (PROCEDURE).
Who is sponsoring clinical trial NCT00444730?
This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
- NCT06161025 · 860 participants · Phase 2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- NCT06541574 · 860 participants · Phase 2
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia